HLS Therapeutics Inc. (TSX: HLS:CA) has published a slide deck for its 2025 fourth-quarter earnings call, released on March 13, 2026, following an earnings summary dated March 12, 2026.
The slide deck, made available on Seeking Alpha, provides visual materials summarizing HLS Therapeutics' Q4 2025 financial results and performance. As a biopharmaceutical company specializing in central nervous system disorders, HLS uses such presentations to share key quarterly insights with investors and stakeholders. The release follows standard practices for publicly traded companies, enabling review of earnings highlights post-call, though specific financial details are within the deck itself.